Have a personal or library account? Click to login
Design, Synthesis and Potential Anti-Proliferative Activity of Some Novel 4-Aminoquinoline Derivatives Cover

Design, Synthesis and Potential Anti-Proliferative Activity of Some Novel 4-Aminoquinoline Derivatives

Open Access
|Oct 2014

References

  1. 1. V. M. Lakshmi, F. F. Hsu and T. V. Zenser, 2-Nitrosoamino-3-methylimidazo[4,5-f]quinoline stability and reactivity, Chem. Res. Toxicol. 17 (2004) 709-716; DOI: 10.1021/tx030042b.10.1021/tx030042b
  2. 2. M. M. Ghorab, A. M. El-Sherief, Y. A. Ammar and S. I. Mohamed, Synthesis and radiation stability of novel biologically active sulfur compounds derived from 1,2-bis(4-amino-5-mercapto-striazol-3-yl)ethane, Farmaco 55 (2000) 354-361.10.1016/S0014-827X(00)00051-3
  3. 3. M. M. Ghorab, F. A. Ragab and M. M. Hamed, Design, synthesis and anticancer evaluation of novel tetrahydroquinoline derivatives containing sulfonamide moiety, Eur. J. Med. Chem. 44 (2009) 4211-4217; DOI: 10.1016/j.ejmech.2009.05.017.10.1016/j.ejmech.2009.05.01719540022
  4. 4. S. Mathan, K. Chandraprakash, C. Uvarani and S. M. Palathurai, Synthesis, antioxidant and toxicological study of novel pyrimido quinoline derivatives from 4-hydroxy-3-acyl quinolin-2-one, Bioorg. Med. Chem. Lett. 20 (2010) 7147-7151; DOI: 10.1016/j.bmcl.2010.09.018.10.1016/j.bmcl.2010.09.01820947350
  5. 5. V. G. Brunton, M. J. Lear, P. Mckeown, D. J. Robins and P. Workman, Synthesis and antiproliferative activity of tyrphostins containing quinoline moieties, Anticancer Drug Res. 11 (1996) 463-483.
  6. 6. E. W. Chia, A. N. Pearce, M. V. Berridge, L. Larsen, N. B. Perry, C. E. Sansom, C. A. Godfrey, L. R. Hanton, G. L. Lu, M. Walton, W. A. Denny, V. L. Webb, B. R. Copp and J. L. Harper, Synthesis and anti-inflammatory structure-activity relationships of thiazine-quinoline-quinones: Inhibitors of the neutrophil respiratory burst in a model of acute gouty arthritis, Bioorg. Med. Chem. 16 (2008) 9432-9442; DOI: 10.1016/j.bmc.2008.09.052.10.1016/j.bmc.2008.09.05218835721
  7. 7. V. R. Solomon and H. Lee, Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies, Eur. J. Pharmacol. 625 (2009) 220-233; DOI: 10.1016/j.ejphar.2009.06.063.10.1016/j.ejphar.2009.06.06319836374
  8. 8. I. Perković, S. Tršinar, J. Žanetić, M. Kralj, I. Martin-Kleiner, J. Balzarini, D. Hadjipavlou-Litina, A. M. Katsori and B. Zorc, Novel 1-acyl-4-substituted semicarbazide derivatives of primaquine − synthesis, cytostatic, antiviral and antioxidative studies, J. Enzyme Inhib. Med. Chem. 28 (2013) 601-610; DOI: 10.3109/14756366.2012.663366.10.3109/14756366.2012.66336622380782
  9. 9. A. S. Abel, A. D. Averin, O. A. Maloshitskaya, E. N. Savelyev, B. S. Orlinson, I. A. Novakov and I. P. Beletskaya, Palladium-catalyzed amination of dichloroquinolines with adamantane-containg amines, Molecules 18 (2013) 2096-2109; DOI: 10.3390/molecules18022096.10.3390/molecules18022096627035723389254
  10. 10. N. Amit, M. Vikramdeep, M. Alpeshkumar, C. Evans and J. Rahul, Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines, Bioorg. Med. Chem. 15 (2007) 626-640; DOI: 10.1016/j.bmc.2006.10.064.10.1016/j.bmc.2006.10.06417107805
  11. 11. M. S. Al-Said, M. M. Ghorab and M. Y. Nissan, Dapson in heterocyclic chemistry, part VIII: synthesis, molecular docking and anticancer activity of some novel sulfonylbiscompounds carrying biologically active 1,3-dihydropyridine, chromene and chromenopyridine moieties, Chem. Cent. J. 6 (2012) Article No. 64; DOI: 10.1186/1752-153X-6-64.10.1186/1752-153X-6-64354339122748424
  12. 12. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, Arch. Pharm. Res. 36 (2013) 660-670; DOI: 10.1007/s12272-013-0094-6.10.1007/s12272-013-0094-623529860
  13. 13. M. S. Al-Dosari, M. M. Ghorab, M. S. Al-Said and M. Y. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents, Chem. Pharm. Bull. 61 (2013) 50-58; DOI: org/10.1248/cpb.c12-00812.10.1248/cpb.c12-0081223302586
  14. 14. M. S. Al-Said, M. S. Bashandy and M. M. Ghorab, Novel quinolines bearing a biologically active trimethoxyphenyl moiety as a new class of antitumor agents, Arzneim. Forsch. 61 (2011) 527-531; DOI: 10.1055/s-0031-1296239.10.1055/s-0031-129623922029230
  15. 15. M. S. Bashandy, M. S. Alsaid, S. I. Alqasoumi and M. M. Ghorab, Design and synthesis of some novel hydrazide, 1,2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity, Arzneim. Forsch. 61 (2011) 521-526; DOI: 10.1055/s-0031-1296238.10.1055/s-0031-129623822029229
  16. 16. M. M. Ghorab, M. S. Al-Said and E. M. El-Hossary, In vitro cytotoxic evaluation of some new heterocyclic sulfonamide derivatives, J. Heterocycl. Chem. 48 (2011) 563-571; DOI: 10.1002/jhet.619.10.1002/jhet.619
  17. 17. M. S. Al-Said, M. S. Bashandy, S. I. Alqasomi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem. 46 (2011) 137-141; DOI: 10.1016/j.ejmech.2010.10.024.10.1016/j.ejmech.2010.10.02421093116
  18. 18 M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, Docking study, in vitro anticancer screening and radiosensitizing evaluation of some new fluorine-containing quinoline and pyrimidoquinoline derivatives bearing a sulfonamide moiety, Med. Chem. Res. 20 (2011) 388-400; DOI: 10.1007/s00044-010-9332-3.10.1007/s00044-010-9332-3
  19. 19. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. 82 (1990) 1107-1112; DOI: 10.1093/jnci/82.13.1107. 10.1093/jnci/82.13.11072359136
DOI: https://doi.org/10.2478/acph-2014-0030 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 285 - 297
Accepted on: May 20, 2014
Published on: Oct 8, 2014
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2014 Mostafa M. Ghorab, Mansour S. Al-Said, Reem K. Arafa, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.